Li Hui Chang

Director of Finance/CFO presso FORMOSA OPTICAL TECHNOLOGY CO.,LTD.

Health Technology

Process Industries

Consumer Services

Profilo

Li Hui Chang is currently working as a Director at Polylite Taiwan Co. Ltd., a Director at Essilor Amera Pte Ltd., and as the Vice President-Finance & Accounting Office at Formosa Optical Technology Co., Ltd.
Mr. Chang completed their undergraduate degree at Fu Jen Catholic University.

Posizioni attive di Li Hui Chang

Società	Posizione	Inizio
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Director of Finance/CFO	06/11/1995
POLYLITE TAIWAN CO., LTD.	Director/Board Member	01/06/2006
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Director/Board Member	-

Tutte le posizioni attive di Li Hui Chang

Formazione di Li Hui Chang

Fu Jen Catholic University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Li Hui Chang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Health Technology
POLYLITE TAIWAN CO., LTD.	Process Industries

Aziende private	1
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Health Technology